*恭喜浙江省农业科学院俞老师在SCI期刊 Environmental Science and Pollution Research(IF:2.914)上成功发表
*恭喜西安理工大学张老师,环境水利专业,文章成功发表在SCI期刊Environmental Science and Pollution Research上,IF2.914
*恭喜山东交通学院谢老师在SCI期刊APPLIED SURFACE SCIENCE(IF5.15)上成功发表
*恭喜华中科技大学黄老师在SCI期刊 ACS Applied Materials & Interfaces(IF8.456)上成功发表
*恭喜中南大学湘雅医院黄医生在Frontiers in Oncology(IF 4.137)上成功发表
*恭喜复旦大学辛博士在SCI期刊 FEBS LETTERS(IF2.675)上成功发表
*恭喜中南大学陈博士在THIN-WALLED STRUCTURESSCI期刊(IF3.488)上成功发表
*恭喜湖南工学院郭老师在SCI期刊SIMULATION MODELLING PRACTICE AND THEORY(IF2.42)上成功发表
*恭喜东华大学闫老师在SCI期刊Advanced Functional Materials(IF 15.621)上成功发表
*恭喜安徽医科大学肖老师在SCI期刊BMC CELL BIOLOGY(IF 3.485)上成功发表
*恭喜四川大学华西医院谢医生在SCI期刊European Heart Journal: Acute Cardiovascular Care(IF 3.734)上成功发表

0591-83301811

周一~周日, 8:00 - 23:00

13107667616

周一~周日, 8:00 - 23:00

service@editideas.cn

随时欢迎您的来信!

2021年最新SCI期刊影响因子查询系统

期刊名称:
ISSN:
期刊研究方向:
IF范围:
中科院分区:
SCI/SCIE:
是否OA期刊:
排列方式:

PEDIATRIC DIABETES 期刊详细信息

基本信息
期刊名称 PEDIATRIC DIABETES
PEDIATRIC DIABETES
期刊ISSN 1399-543X
期刊官方网站 http://link.springer.com/journal/40272
是否OA
出版商 Adis International Ltd
出版周期
始发年份 1999
年文章数 52
最新影响因子 3.409(2021)
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学4区 PEDIATRICS 儿科3区
PHARMACOLOGY & PHARMACY 药学4区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 2.06 0.620 0.980
Medicine
Pediatrics, Perinatology, and Child Health
62 / 277 77%
Medicine
Pharmacology (medical)
97 / 232 58%
补充信息
自引率 1.80%
H-index 51
SCI收录状况 Science Citation Index Expanded
官方审稿时间
32 days Submission to first decision
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1174-5878%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/pdda/default.aspx
收稿范围
Pediatric Drugs promotes the optimization and advancement of all aspects of pharmacotherapy for healthcare professionals interested in pediatric drug therapy (including vaccines). The program of review and original research articles provides healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology and the care of children and adolescents. The Journal includes:
overviews of contentious or emerging issues.
comprehensive narrative reviews of topics relating to the effective and safe management of drug therapy through all stages of pediatric development.
practical reviews covering optimum drug management of specific clinical situations.
systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in the pediatric population.
original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.

Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Pediatric Drugs may be accompanied by plain language summaries to assist readers in understanding important medical advances.
All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.
收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息
近期成功发表案例展示